GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ben Tre Pharmaceutical JSC (STC:DBT) » Definitions » EPS (Basic)

Ben Tre Pharmaceutical JSC (STC:DBT) EPS (Basic) : ₫ (TTM As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Ben Tre Pharmaceutical JSC EPS (Basic)?

Ben Tre Pharmaceutical JSC's basic earnings per share (Basic EPS) for the six months ended in . 20 was ₫0.00. Ben Tre Pharmaceutical JSC does not have enough years/quarters to calculate its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in . 20.

Ben Tre Pharmaceutical JSC's EPS (Diluted) for the six months ended in . 20 was ₫0.00. Ben Tre Pharmaceutical JSC does not have enough years/quarters to calculate its EPS (Diluted) for the trailing twelve months (TTM) ended in . 20.

Ben Tre Pharmaceutical JSC's EPS without NRI for the six months ended in . 20 was ₫0.00. Ben Tre Pharmaceutical JSC does not have enough years/quarters to calculate its EPS without NRI for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Ben Tre Pharmaceutical JSC EPS (Basic) Historical Data

The historical data trend for Ben Tre Pharmaceutical JSC's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ben Tre Pharmaceutical JSC EPS (Basic) Chart

Ben Tre Pharmaceutical JSC Annual Data
Trend
EPS (Basic)

Ben Tre Pharmaceutical JSC Semi-Annual Data
EPS (Basic)

Ben Tre Pharmaceutical JSC EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Ben Tre Pharmaceutical JSC's Basic EPS for the fiscal year that ended in . 20 is calculated as


Ben Tre Pharmaceutical JSC's Basic EPS for the quarter that ended in . 20 is calculated as


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ben Tre Pharmaceutical JSC  (STC:DBT) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Ben Tre Pharmaceutical JSC EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Ben Tre Pharmaceutical JSC's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Ben Tre Pharmaceutical JSC Business Description

Traded in Other Exchanges
N/A
Address
6A3, 60 National Highway, Phu Tan Ward, Ben Tre Town, Ben Tre, VNM
Ben Tre Pharmaceutical JSC is engaged in producing and trading of medicine. It also imports medicine, package, materials additives, and flavoring for production. It manufactures and distributes medicament and health equipment in Ho Chi Minh, Hanoi, Danang, and Can Tho.

Ben Tre Pharmaceutical JSC Headlines

No Headlines